United Therapeutics Plans Five Presentations And One Poster Across Its Commercial And Development Portfolio At The CHEST 2024 Annual Meeting
United Therapeutics Plans Five Presentations And One Poster Across Its Commercial And Development Portfolio At The CHEST 2024 Annual Meeting
美國聯合醫療計劃在CHESt 2024年年會上展示五個演講和一個海報，涵蓋其商業和發展領域。
Data from the BREEZE open-label extension study of Tyvaso DPI detail its long-term outcomes and dosing in patients with pulmonary arterial hypertension.
來自BREEZE開放標籤延長研究的Tyvaso DPI數據詳細介紹了其長期效果以及對肺動脈高壓患者的用藥。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間